Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (84)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Dinkova-Kostova, A. T.
Right arrow Articles by Talalay, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dinkova-Kostova, A. T.
Right arrow Articles by Talalay, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 20, No. 5, 911-914, May 1999
© 1999 Oxford University Press


Short Communications

Relation of structure of curcumin analogs to their potencies as inducers of Phase 2 detoxification enzymes

Albena T. Dinkova-Kostova and Paul Talalay1

Department of Pharmacology and Molecular Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA

A series of naturally occurring as well as synthetic structural analogs of the dietary constituent curcumin were examined in order to elucidate which portions of the molecule are critical for the ability to induce Phase 2 detoxification enzymes in murine hepatoma cells, and hence to assess the chemoprotective potential of these compounds. Two groups of compounds were studied: classical Michael reaction acceptors such as curcumin and related ß-diketones such as dibenzoylmethane which lack direct Michael reactivity. The presence of two structural elements was found to be required for high inducer potency: (i) hydroxyl groups at ortho-position on the aromatic rings and (ii) the ß-diketone functionality. All curcuminoids elevate the specific activity of quinone reductase in both wild type and mutant cells defective in either the aryl hydrocarbon (Ah) receptor or cytochrome P4501A1 activity. This indicates that neither binding to this receptor, nor metabolic activation by P4501A1 are required for the signaling process originating from this family of electrophiles and ultimately resulting in Phase 2 enzyme induction.

Abbreviations: Ah receptor, aryl hydrocarbon receptor; DMBA, 7,12-dimethylbenz[a]anthracene; NF-{kappa}B, nuclear factor {kappa}B; QR, quinone reductase; TPA, 12-O-tetradecanoylphorbol-13-acetate.

1 To whom correspondence should be addressed Email: ptalalay{at}welchlink.welch.jhu.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BloodHome page
Y. Jiao, J. Wilkinson IV, X. Di, W. Wang, H. Hatcher, N. D. Kock, R. D'Agostino Jr, M. A. Knovich, F. M. Torti, and S. V. Torti
Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator
Blood, January 8, 2009; 113(2): 462 - 469.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Pugazhenthi, L. Akhov, G. Selvaraj, M. Wang, and J. Alam
Regulation of heme oxygenase-1 expression by demethoxy curcuminoids through Nrf2 by a PI3-kinase/Akt-mediated pathway in mouse beta-cells
Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E645 - E655.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C.-C. Lin, Y.-L. Tsai, M.-T. Huang, Y.-P. Lu, C.-T. Ho, S.-F. Tseng, and S.-C. Teng
Inhibition of estradiol-induced mammary proliferation by dibenzoylmethane through the E2-ER-ERE-dependent pathway
Carcinogenesis, January 1, 2006; 27(1): 131 - 136.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
N. Jurrmann, R. Brigelius-Flohe, and G.-F. Bol
Curcumin Blocks Interleukin-1 (IL-1) Signaling by Inhibiting the Recruitment of the IL-1 Receptor-Associated Kinase IRAK in Murine Thymoma EL-4 Cells
J. Nutr., August 1, 2005; 135(8): 1859 - 1864.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
E. Tourkina, P. Gooz, J. C. Oates, A. Ludwicka-Bradley, R. M. Silver, and S. Hoffman
Curcumin-Induced Apoptosis in Scleroderma Lung Fibroblasts: Role of Protein Kinase C{epsilon}
Am. J. Respir. Cell Mol. Biol., July 1, 2004; 31(1): 28 - 35.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Bai, F. Cerimele, M. Ushio-Fukai, M. Waqas, P. M. Campbell, B. Govindarajan, C. J. Der, T. Battle, D. A. Frank, K. Ye, et al.
Honokiol, a Small Molecular Weight Natural Product, Inhibits Angiogenesis in Vitro and Tumor Growth in Vivo
J. Biol. Chem., September 12, 2003; 278(37): 35501 - 35507.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. D. Brooks, M. F. Goldberg, L. A. Nelson, D. Wu, and W. G. Nelson
Identification of Potential Prostate Cancer Preventive Agents through Induction of Quinone Reductase in Vitro
Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 868 - 875.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Scapagnini, R. Foresti, V. Calabrese, A. M. G. Stella, C. J. Green, and R. Motterlini
Caffeic Acid Phenethyl Ester and Curcumin: A Novel Class of Heme Oxygenase-1 Inducers
Mol. Pharmacol., March 1, 2002; 61(3): 554 - 561.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. R. Ireson, D. J. L. Jones, S. Orr, M. W. H. Coughtrie, D. J. Boocock, M. L. Williams, P. B. Farmer, W. P. Steward, and A. J. Gescher
Metabolism of the Cancer Chemopreventive Agent Curcumin in Human and Rat Intestine
Cancer Epidemiol. Biomarkers Prev., January 1, 2002; 11(1): 105 - 111.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. T. Dinkova-Kostova, M. A. Massiah, R. E. Bozak, R. J. Hicks, and P. Talalay
From the Cover: Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups
PNAS, March 13, 2001; 98(6): 3404 - 3409.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Ireson, S. Orr, D. J. L. Jones, R. Verschoyle, C.-K. Lim, J.-L. Luo, L. Howells, S. Plummer, R. Jukes, M. Williams, et al.
Characterization of Metabolites of the Chemopreventive Agent Curcumin in Human and Rat Hepatocytes and in the Rat in Vivo, and Evaluation of Their Ability to Inhibit Phorbol Ester-induced Prostaglandin E2 Production
Cancer Res., February 1, 2001; 61(3): 1058 - 1064.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
V. P. Kelly, E. M. Ellis, M. M. Manson, S. A. Chanas, G. J. Moffat, R. McLeod, D. J. Judah, G. E. Neal, and J. D. Hayes
Chemoprevention of Aflatoxin B1 Hepatocarcinogenesis by Coumarin, a Natural Benzopyrone That Is a Potent Inducer of Aflatoxin B1-Aldehyde Reductase, the Glutathione S-Transferase A5 and P1 Subunits, and NAD(P)H:Quinone Oxidoreductase in Rat Liver
Cancer Res., February 1, 2000; 60(4): 957 - 969.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.